HEADER ISOMERASE 11-JUN-08 2VVT TITLE GLUTAMATE RACEMASE (MURI) FROM E. FAECALIS IN COMPLEX WITH TITLE 2 A 9-BENZYL PURINE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUTAMATE RACEMASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 1-270; COMPND 5 EC: 5.1.1.3; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ENTEROCOCCUS FAECALIS; SOURCE 3 ORGANISM_TAXID: 1351; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ISOMERASE, GLUTAMATE RACEMASE, PEPTIDOGLYCAN SYNTHESIS, KEYWDS 2 CELL WALL BIOGENESIS/DEGRADATION, CELL SHAPE, BENZYL KEYWDS 3 PURINE, MURI INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR B.GENG,G.BREAULT,J.COMITA-PREVOIR,R.PETRICHKO,C.EYERMANN, AUTHOR 2 T.LUNDQVIST,P.DOIG,E.GORSETH,B.NOONAN REVDAT 3 24-FEB-09 2VVT 1 VERSN REVDAT 2 05-AUG-08 2VVT 1 JRNL REMARK REVDAT 1 24-JUN-08 2VVT 0 JRNL AUTH B.GENG,G.BREAULT,J.COMITA-PREVOIR,R.PETRICHKO, JRNL AUTH 2 C.EYERMANN,T.LUNDQVIST,P.DOIG,E.GORSETH,B.NOONAN JRNL TITL EXPLORING 9-BENZYL PURINES AS INHIBITORS OF JRNL TITL 2 GLUTAMATE RACEMASE (MURI) IN GRAM-POSITIVE JRNL TITL 3 BACTERIA. JRNL REF BIOORG.MED.CHEM.LETT. V. 18 4368 2008 JRNL REFN ISSN 0960-894X JRNL PMID 18614367 JRNL DOI 10.1016/J.BMCL.2008.06.068 REMARK 2 REMARK 2 RESOLUTION. 1.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 81.65 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 94.8 REMARK 3 NUMBER OF REFLECTIONS : 56198 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.152 REMARK 3 R VALUE (WORKING SET) : 0.150 REMARK 3 FREE R VALUE : 0.184 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 3003 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.65 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.69 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4121 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.1550 REMARK 3 BIN FREE R VALUE SET COUNT : 254 REMARK 3 BIN FREE R VALUE : 0.2070 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4049 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 84 REMARK 3 SOLVENT ATOMS : 703 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 11.57 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.66000 REMARK 3 B22 (A**2) : -0.49000 REMARK 3 B33 (A**2) : -0.17000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.093 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.092 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.053 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.502 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.963 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.946 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4209 ; 0.014 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2760 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5715 ; 1.461 ; 2.006 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6841 ; 0.920 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 532 ; 5.386 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 142 ;40.771 ;25.000 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 731 ;12.159 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 15 ;14.686 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 682 ; 0.087 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4548 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 721 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 972 ; 0.227 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 2965 ; 0.196 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2103 ; 0.182 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 2060 ; 0.087 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 474 ; 0.175 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 21 ; 0.118 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 79 ; 0.229 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 68 ; 0.195 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2784 ; 1.047 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4330 ; 1.475 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1659 ; 2.426 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1385 ; 3.694 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. REMARK 4 REMARK 4 2VVT COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-JUN-08. REMARK 100 THE PDBE ID CODE IS EBI-36519. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-JUN-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9757 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 205055 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.65 REMARK 200 RESOLUTION RANGE LOW (A) : 81.65 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.1 REMARK 200 DATA REDUNDANCY : 3.5 REMARK 200 R MERGE (I) : 0.08 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.60 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.6 REMARK 200 R MERGE FOR SHELL (I) : 0.13 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.10 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2JFO REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN FORMULATED AT 10 MG/ML REMARK 280 WITH 200MM AMMONIUM ACETATE PH 7.4, 5MM D-L GLUTAMATE, 1 REMARK 280 MM TCEP AND CRYSTALLISED WITH 0.2 MM MGCL2 AND 20-25% PEG REMARK 280 3350, 100 MM TRIS PH 7.5, 20% GLYCEROL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.20100 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 82.56000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.71600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 82.56000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.20100 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 34.71600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 2960 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 26320 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -19 REMARK 465 GLY A -18 REMARK 465 SER A -17 REMARK 465 SER A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 SER A -9 REMARK 465 SER A -8 REMARK 465 GLY A -7 REMARK 465 LEU A -6 REMARK 465 GLU A 230 REMARK 465 ALA A 231 REMARK 465 PRO A 232 REMARK 465 THR A 233 REMARK 465 GLN A 234 REMARK 465 ASN A 270 REMARK 465 MET B -19 REMARK 465 GLY B -18 REMARK 465 SER B -17 REMARK 465 SER B -16 REMARK 465 HIS B -15 REMARK 465 HIS B -14 REMARK 465 HIS B -13 REMARK 465 HIS B -12 REMARK 465 HIS B -11 REMARK 465 HIS B -10 REMARK 465 SER B -9 REMARK 465 SER B -8 REMARK 465 GLY B -7 REMARK 465 LEU B -6 REMARK 465 VAL B -5 REMARK 465 PRO B -4 REMARK 465 ARG B -3 REMARK 465 GLY B -2 REMARK 465 SER B -1 REMARK 465 HIS B 0 REMARK 465 MET B 1 REMARK 465 SER B 2 REMARK 465 GLY B 269 REMARK 465 ASN B 270 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLY A 269 CA C O REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER A 126 - O HOH A 2162 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 259 35.93 -98.93 REMARK 500 GLN B 156 53.26 -112.80 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE I24 A1269 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE I24 B1269 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DGL A1270 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DGL B1270 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2JFP RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ENTEROCOCCUS FAECALIS REMARK 900 GLUTAMATE RACEMASE IN COMPLEX WITH D- REMARK 900 GLUTAMATE REMARK 900 RELATED ID: 2JFO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ENTEROCOCCUS FAECALIS REMARK 900 GLUTAMATE RACEMASE IN COMPLEX WITH D- AND REMARK 900 L-GLUTAMATE REMARK 999 REMARK 999 SEQUENCE REMARK 999 DATABASE REFERENCE GENESEQP ADR04180 (PATENT DATABASE.) REMARK 999 CLOSEST PUBLIC REFERENCE IS GENPEPT NP_814851 HAS 2 REMARK 999 DIFFERENCES AT RESIDUE 137 AND 144 (THR AND ASP IN REMARK 999 NP_814851) DBREF 2VVT A -19 0 PDB 2VVT 2VVT -19 0 DBREF 2VVT A 1 270 UNP Q836J0 MURI_ENTFA 1 270 DBREF 2VVT B -19 0 PDB 2VVT 2VVT -19 0 DBREF 2VVT B 1 270 UNP Q836J0 MURI_ENTFA 1 270 SEQADV 2VVT ALA A 137 UNP Q836J0 THR 137 CONFLICT SEQADV 2VVT ALA A 144 UNP Q836J0 ASP 144 CONFLICT SEQADV 2VVT ALA B 137 UNP Q836J0 THR 137 CONFLICT SEQADV 2VVT ALA B 144 UNP Q836J0 ASP 144 CONFLICT SEQRES 1 A 290 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 290 LEU VAL PRO ARG GLY SER HIS MET SER ASN GLN GLU ALA SEQRES 3 A 290 ILE GLY LEU ILE ASP SER GLY VAL GLY GLY LEU THR VAL SEQRES 4 A 290 LEU LYS GLU ALA LEU LYS GLN LEU PRO ASN GLU ARG LEU SEQRES 5 A 290 ILE TYR LEU GLY ASP THR ALA ARG CYS PRO TYR GLY PRO SEQRES 6 A 290 ARG PRO ALA GLU GLN VAL VAL GLN PHE THR TRP GLU MET SEQRES 7 A 290 ALA ASP PHE LEU LEU LYS LYS ARG ILE LYS MET LEU VAL SEQRES 8 A 290 ILE ALA CYS ASN THR ALA THR ALA VAL ALA LEU GLU GLU SEQRES 9 A 290 ILE LYS ALA ALA LEU PRO ILE PRO VAL VAL GLY VAL ILE SEQRES 10 A 290 LEU PRO GLY ALA ARG ALA ALA VAL LYS VAL THR LYS ASN SEQRES 11 A 290 ASN LYS ILE GLY VAL ILE GLY THR LEU GLY THR ILE LYS SEQRES 12 A 290 SER ALA SER TYR GLU ILE ALA ILE LYS SER LYS ALA PRO SEQRES 13 A 290 ALA ILE GLU VAL THR SER LEU ALA CYS PRO LYS PHE VAL SEQRES 14 A 290 PRO ILE VAL GLU SER ASN GLN TYR ARG SER SER VAL ALA SEQRES 15 A 290 LYS LYS ILE VAL ALA GLU THR LEU GLN ALA LEU GLN LEU SEQRES 16 A 290 LYS GLY LEU ASP THR LEU ILE LEU GLY CYS THR HIS TYR SEQRES 17 A 290 PRO LEU LEU ARG PRO VAL ILE GLN ASN VAL MET GLY SER SEQRES 18 A 290 HIS VAL THR LEU ILE ASP SER GLY ALA GLU THR VAL GLY SEQRES 19 A 290 GLU VAL SER MET LEU LEU ASP TYR PHE ASP ILE ALA HIS SEQRES 20 A 290 THR PRO GLU ALA PRO THR GLN PRO HIS GLU PHE TYR THR SEQRES 21 A 290 THR GLY SER ALA LYS MET PHE GLU GLU ILE ALA SER SER SEQRES 22 A 290 TRP LEU GLY ILE GLU ASN LEU LYS ALA GLN GLN ILE HIS SEQRES 23 A 290 LEU GLY GLY ASN SEQRES 1 B 290 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 290 LEU VAL PRO ARG GLY SER HIS MET SER ASN GLN GLU ALA SEQRES 3 B 290 ILE GLY LEU ILE ASP SER GLY VAL GLY GLY LEU THR VAL SEQRES 4 B 290 LEU LYS GLU ALA LEU LYS GLN LEU PRO ASN GLU ARG LEU SEQRES 5 B 290 ILE TYR LEU GLY ASP THR ALA ARG CYS PRO TYR GLY PRO SEQRES 6 B 290 ARG PRO ALA GLU GLN VAL VAL GLN PHE THR TRP GLU MET SEQRES 7 B 290 ALA ASP PHE LEU LEU LYS LYS ARG ILE LYS MET LEU VAL SEQRES 8 B 290 ILE ALA CYS ASN THR ALA THR ALA VAL ALA LEU GLU GLU SEQRES 9 B 290 ILE LYS ALA ALA LEU PRO ILE PRO VAL VAL GLY VAL ILE SEQRES 10 B 290 LEU PRO GLY ALA ARG ALA ALA VAL LYS VAL THR LYS ASN SEQRES 11 B 290 ASN LYS ILE GLY VAL ILE GLY THR LEU GLY THR ILE LYS SEQRES 12 B 290 SER ALA SER TYR GLU ILE ALA ILE LYS SER LYS ALA PRO SEQRES 13 B 290 ALA ILE GLU VAL THR SER LEU ALA CYS PRO LYS PHE VAL SEQRES 14 B 290 PRO ILE VAL GLU SER ASN GLN TYR ARG SER SER VAL ALA SEQRES 15 B 290 LYS LYS ILE VAL ALA GLU THR LEU GLN ALA LEU GLN LEU SEQRES 16 B 290 LYS GLY LEU ASP THR LEU ILE LEU GLY CYS THR HIS TYR SEQRES 17 B 290 PRO LEU LEU ARG PRO VAL ILE GLN ASN VAL MET GLY SER SEQRES 18 B 290 HIS VAL THR LEU ILE ASP SER GLY ALA GLU THR VAL GLY SEQRES 19 B 290 GLU VAL SER MET LEU LEU ASP TYR PHE ASP ILE ALA HIS SEQRES 20 B 290 THR PRO GLU ALA PRO THR GLN PRO HIS GLU PHE TYR THR SEQRES 21 B 290 THR GLY SER ALA LYS MET PHE GLU GLU ILE ALA SER SER SEQRES 22 B 290 TRP LEU GLY ILE GLU ASN LEU LYS ALA GLN GLN ILE HIS SEQRES 23 B 290 LEU GLY GLY ASN HET I24 A1269 32 HET I24 B1269 32 HET DGL A1270 10 HET DGL B1270 10 HETNAM I24 2-BUTOXY-9-(2,6-DIFLUOROBENZYL)-N-(2- HETNAM 2 I24 MORPHOLIN-4-YLETHYL)-9H-PURIN-6-AMINE HETNAM DGL D-GLUTAMIC ACID FORMUL 3 I24 2(C22 H28 N6 O2 F2) FORMUL 4 DGL 2(C5 H9 N O4) FORMUL 5 HOH *703(H2 O1) HELIX 1 1 MET A 1 GLU A 5 5 5 HELIX 2 2 GLY A 16 LEU A 27 1 12 HELIX 3 3 PRO A 47 LYS A 64 1 18 HELIX 4 4 CYS A 74 LEU A 89 1 16 HELIX 5 5 ILE A 97 THR A 108 1 12 HELIX 6 6 THR A 118 SER A 124 1 7 HELIX 7 7 ALA A 125 SER A 133 1 9 HELIX 8 8 LYS A 147 SER A 154 1 8 HELIX 9 9 SER A 159 GLN A 171 1 13 HELIX 10 10 ALA A 172 GLN A 174 5 3 HELIX 11 11 HIS A 187 LEU A 190 5 4 HELIX 12 12 LEU A 191 GLY A 200 1 10 HELIX 13 13 SER A 208 PHE A 223 1 16 HELIX 14 14 SER A 243 GLY A 256 1 14 HELIX 15 15 GLY B 16 LEU B 27 1 12 HELIX 16 16 THR B 38 CYS B 41 5 4 HELIX 17 17 PRO B 47 LYS B 64 1 18 HELIX 18 18 CYS B 74 LEU B 89 1 16 HELIX 19 19 ILE B 97 THR B 108 1 12 HELIX 20 20 THR B 118 SER B 124 1 7 HELIX 21 21 ALA B 125 ALA B 135 1 11 HELIX 22 22 LYS B 147 SER B 154 1 8 HELIX 23 23 SER B 159 LEU B 175 1 17 HELIX 24 24 HIS B 187 LEU B 190 5 4 HELIX 25 25 LEU B 191 GLY B 200 1 10 HELIX 26 26 SER B 208 PHE B 223 1 16 HELIX 27 27 SER B 243 GLY B 256 1 14 SHEET 1 AA 6 VAL A 93 GLY A 95 0 SHEET 2 AA 6 MET A 69 ILE A 72 1 O LEU A 70 N VAL A 94 SHEET 3 AA 6 ILE A 7 ASP A 11 1 O GLY A 8 N VAL A 71 SHEET 4 AA 6 LEU A 32 GLY A 36 1 O ILE A 33 N LEU A 9 SHEET 5 AA 6 GLU A 237 THR A 240 1 O GLU A 237 N TYR A 34 SHEET 6 AA 6 ALA A 262 GLN A 264 1 O GLN A 263 N THR A 240 SHEET 1 AB 4 GLU A 139 ALA A 144 0 SHEET 2 AB 4 LYS A 112 GLY A 117 1 O ILE A 113 N THR A 141 SHEET 3 AB 4 THR A 180 LEU A 183 1 O THR A 180 N GLY A 114 SHEET 4 AB 4 THR A 204 ASP A 207 1 O THR A 204 N LEU A 181 SHEET 1 BA 6 VAL B 93 GLY B 95 0 SHEET 2 BA 6 MET B 69 ILE B 72 1 O LEU B 70 N VAL B 94 SHEET 3 BA 6 ILE B 7 ASP B 11 1 O GLY B 8 N VAL B 71 SHEET 4 BA 6 LEU B 32 GLY B 36 1 O ILE B 33 N LEU B 9 SHEET 5 BA 6 GLU B 237 THR B 240 1 O GLU B 237 N TYR B 34 SHEET 6 BA 6 GLN B 263 GLN B 264 1 O GLN B 263 N THR B 240 SHEET 1 BB 4 GLU B 139 ALA B 144 0 SHEET 2 BB 4 LYS B 112 GLY B 117 1 O ILE B 113 N THR B 141 SHEET 3 BB 4 THR B 180 LEU B 183 1 O THR B 180 N GLY B 114 SHEET 4 BB 4 THR B 204 ASP B 207 1 O THR B 204 N LEU B 181 CISPEP 1 CYS A 41 PRO A 42 0 1.62 CISPEP 2 CYS B 41 PRO B 42 0 2.10 SITE 1 AC1 11 VAL A 14 VAL A 152 GLU A 153 ASN A 155 SITE 2 AC1 11 HIS A 187 LEU A 190 MET A 246 ILE A 250 SITE 3 AC1 11 HOH A2194 HOH A2313 HOH A2314 SITE 1 AC2 12 ASN A 197 GLY A 200 SER A 201 HIS A 202 SITE 2 AC2 12 HOH A2235 VAL B 152 GLU B 153 ASN B 155 SITE 3 AC2 12 GLU B 249 ILE B 250 HOH B2355 HOH B2386 SITE 1 AC3 14 ASP A 11 SER A 12 PRO A 42 TYR A 43 SITE 2 AC3 14 GLY A 44 CYS A 74 ASN A 75 THR A 76 SITE 3 AC3 14 THR A 118 CYS A 185 THR A 186 HOH A2021 SITE 4 AC3 14 HOH A2230 HOH A2315 SITE 1 AC4 14 ASP B 11 SER B 12 PRO B 42 TYR B 43 SITE 2 AC4 14 GLY B 44 CYS B 74 ASN B 75 THR B 76 SITE 3 AC4 14 THR B 118 CYS B 185 THR B 186 HIS B 187 SITE 4 AC4 14 HOH B2282 HOH B2388 CRYST1 44.402 69.432 165.120 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022522 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014403 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006056 0.00000 MASTER 364 0 4 27 20 0 14 6 0 0 0 46 END